Search research articles
Contact Us
Filters
Showing results (131-140 of 204) with videos related to
Page
of 21
Sort By:
The Prostate
|
July 24, 2015
Metformin effects on biochemical recurrence and metabolic signaling in the prostate
Brian Winters, Stephen Plymate, Steven B Zeliadt, et al.
Advances in Urology
|
January 3, 2014
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
Franklin C Lee, William Harris, Heather H Cheng, et al.
Clinical Epigenetics
|
September 22, 2016
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
Milan S Geybels, Jonathan L Wright, Marina Bibikova, et al.
European Urology
|
March 8, 2014
Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control
Jim C Hu, Giorgio Gandaglia, Pierre I Karakiewicz, et al.
Genomics
|
February 24, 2016
DNA methylation profiles in African American prostate cancer patients in relation to disease progression
Rohina Rubicz, Shanshan Zhao, Milan Geybels, et al.
The Prostate
|
May 21, 2015
Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort
Rohina Rubicz, Shanshan Zhao, Craig April, et al.
Clinical Genitourinary Cancer
|
December 24, 2013
Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladder
Matthew Mossanen, Franklin Lee, Heather Cheng, et al.
The Journal of Urology
|
January 26, 2016
Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy
George R Schade, Sarah K Holt, Xiaotun Zhang, et al.
Clinical Genitourinary Cancer
|
February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancer
Andrew C James, Franklin C Lee, Jason P Izard, et al.
Prostate Cancer and Prostatic Diseases
|
February 20, 2020
Copy number alterations are associated with metastatic-lethal progression in prostate cancer
Xiaoyu Wang, Catherine S Grasso, Kristina M Jordahl, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 204) with videos related to
Sort By:
Page
of 21
The Prostate
|
July 24, 2015
Metformin effects on biochemical recurrence and metabolic signaling in the prostate
Brian Winters, Stephen Plymate, Steven B Zeliadt, et al.
Advances in Urology
|
January 3, 2014
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
Franklin C Lee, William Harris, Heather H Cheng, et al.
Clinical Epigenetics
|
September 22, 2016
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
Milan S Geybels, Jonathan L Wright, Marina Bibikova, et al.
European Urology
|
March 8, 2014
Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control
Jim C Hu, Giorgio Gandaglia, Pierre I Karakiewicz, et al.
Genomics
|
February 24, 2016
DNA methylation profiles in African American prostate cancer patients in relation to disease progression
Rohina Rubicz, Shanshan Zhao, Milan Geybels, et al.
The Prostate
|
May 21, 2015
Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort
Rohina Rubicz, Shanshan Zhao, Craig April, et al.
Clinical Genitourinary Cancer
|
December 24, 2013
Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladder
Matthew Mossanen, Franklin Lee, Heather Cheng, et al.
The Journal of Urology
|
January 26, 2016
Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy
George R Schade, Sarah K Holt, Xiaotun Zhang, et al.
Clinical Genitourinary Cancer
|
February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancer
Andrew C James, Franklin C Lee, Jason P Izard, et al.
Prostate Cancer and Prostatic Diseases
|
February 20, 2020
Copy number alterations are associated with metastatic-lethal progression in prostate cancer
Xiaoyu Wang, Catherine S Grasso, Kristina M Jordahl, et al.
Page
of 21